<DOC>
	<DOCNO>NCT00348556</DOCNO>
	<brief_summary>The objective study determine safety effectiveness intrarenal administration brain natriuretic peptide ( BNP ) improve renal function measure glomerular filtration rate ( GFR ) sodium excretion patient hospitalize acute congestive heart failure ( CHF ) deterioration kidney function ( cardiorenal syndrome ) .</brief_summary>
	<brief_title>Use Nesiritide ( BNP ) Kidney Function Patients With Congestive Heart Failure ( CHF ) Kidney Failure</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardio-Renal Syndrome</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Inclusion Criteria Age 18 year old Clinical diagnosis class IIIIV CHF require hospitalization Current acute CHF decompensation Systolic BP &gt; 90 mmHg Stable cardiac rhythm Estimated creatinine clearance CockcroftGault equation less equal 60 mL/min . Worsening renal function great equal 24 hour standard therapy define plasma creatinine concentration great admission 0.3 mg/dL 10 % increase hospital admission creatinine OR creatinine remain 0.3 mg/dL 10 % increase baseline draw do within 4 week hospitalization Ability provide inform consent Exclusion Criteria Patients need emergency coronary revascularization may rapidly change cardiac function ( i.e. , patient acute myocardial infarction shock ) Peritoneal hemodialysis within 90 day anticipation dialysis ultrafiltration form require study period Systolic blood pressure &lt; 90 mmHg cardiogenic shock Requirement pressor maintenance blood pressure Intraaortic blood pump use History significant uncorrected renal artery stenosis define &gt; 50 % stenosis Severe aortic mitral stenosis significant LV outflow tract obstruction Pregnant nursing woman Prisoners Contraindication nesiritide Contraindication heparin Cause acute renal dysfunction reasonably ascribe factor heart failure treatment Inability NSAID dose hold 30 hour , treat medication Ongoing treatment calcineurin inhibitor ( cyclosporine tacrolimus ) Administration radiocontrast medium within 7 day enrollment anticipate use agent study ( minimal contrast required place renal infusion catheter ) Known bleed diathesis Known condition would increase likelihood vascular perforation trauma , dissection Marfan 's syndrome , cystic medial necrosis , abdominal thoracoabdominal aortic dissection , mycotic aneurysm , abdominal aneurysm , thoracoabdominal aneurysm , renal artery aneurysm , thoracic aneurysm involve visceral region aorta , severe calcification area renal artery Solitary kidney solitary functioning kidney Iodine allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>